Anti-TGF-<i>ß</i>1 Antibody Therapy in Patients with Diabetic Nephropathy.
Voelker, James; Berg, Paul H; Sheetz, Matthew; Duffin, Kevin; Shen, Tong; Moser, Brian; Greene, Tom; Blumenthal, Samuel S; Rychlik, Ivan; Yagil, Yoram; Zaoui, Philippe; Lewis, Julia B.
J Am Soc Nephrol
; 28(3): 953-962, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-27647855
TGF-ß: the connecting link between nephropathy and fibrosis.
CXCL16 deficiency attenuates diabetic nephropathy through decreasing oxidative stress and inflammation.
Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells.
Investigation of the influence of nephropathy on monoclonal antibody disposition: a pharmacokinetic study in a mouse model of diabetic nephropathy.
Toll-like receptors: sensing and reacting to diabetic injury in the kidney.
Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis.
Epigenetics in diabetic nephropathy, immunity and metabolism.
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.
Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.
Methylation status of immune response genes promoters in cell-free DNA differs in hemodialyzed patients with diabetic nephropathy according to the intensity of anemia therapy.